トルコでのウィルムス腫瘍治療—3つのパーソナライズクリニックマッチングを取得

Highly-rated specialists for Wilms tumor in Turkey include Dr. Ceyhun Bozkurt and Dr. Ahmet Nadir Tosyali, who offer expertise in pediatric oncology and specialized surgical care. These experts hold credentials from institutions like Harvard and maintain certifications in pediatric surgical oncology and hematology.

• Surgical expertise. Dr. Ahmet Nadir Tosyali at Anadolu performs complex surgeries for pediatric kidney tumors.
• Harvard-trained specialist. Dr. Ceyhun Bozkurt heads the pediatric clinic at Medical Park Bahcelievler in Istanbul.
• Academic leadership. Professor Hilmi Apak has 30+ years of experience focusing on childhood cancer treatments.
• Advanced research. Dr. Sema Yilmaz at Koru Ankara Hospital researches cell therapies for childhood cancers.

Bookimed Expert Insight: Patients seeking treatment for Wilms tumor in Turkey benefit from an integrated approach where pediatric surgeons and oncologists, such as those at Anadolu Medical Center, coordinate closely. This center's affiliation with Johns Hopkins Medicine means treatment protocols for kidney cancers follow globally recognized standards while remaining accessible for international families.

Patient Consensus: Families appreciate that major hospitals in Istanbul can start treatment within days, offering rapid transitions from diagnosis to surgery. The presence of multilingual support staff helps parents understand the process without needing to manage language barriers or logistics themselves.

Anadolu Medical Center and Memorial Sisli are among the most popular Turkish hospitals for Wilms tumor treatment. These centers hold JCI accreditation and provide multidisciplinary care. They feature specialists with international training from institutions like Johns Hopkins and Rambam Medical Center.

• International affiliation. Anadolu Medical Center works with Johns Hopkins Medicine, bringing US healthcare standards to Istanbul.
• Expert specialists. Prof. Dr. Yesim Yildirim at Anadolu is an ESMO-certified oncologist specializing in targeted therapies.
• Academic leadership. Top doctors often serve as professors, ensuring your child receives research-backed treatment protocols.
• Advanced technology. Clinics use precise tools like the TrueBeam STx to target tumors while protecting healthy tissue.

Bookimed Expert Insight: Patients often choose Anadolu Medical Center because it holds the OECI accreditation. This certificate is only given to centers that meet strict European standards for cancer care quality. Many top doctors here, such as Prof. Dr. Yesim Yildirim, have published 80+ scientific studies. This academic depth is vital for treating complex pediatric cases like nephroblastoma.

Patient Consensus: Parents often mention feeling a sense of relief after meeting the multidisciplinary teams in Istanbul. They noticed how specialists explain every step of the treatment plan clearly in English. Many were surprised by the child-friendly hospital environments that help reduce stress during chemotherapy.

Turkish pediatric oncologists follow the SIOP protocol for Wilms tumor, often starting with preoperative chemotherapy to shrink the tumor. Specialists like Dr. Ceyhun Bozkurt and Dr. Hilmi Apak perform nephrectomy, which is a surgery to remove the kidney, and administer vincristine-based drug regimens.

• Surgical resection. Surgeons perform total nephrectomy or kidney-sparing surgery to remove the cancerous mass.
• Neoadjuvant chemotherapy. Doctors usually provide several weeks of upfront chemotherapy to make surgery safer.
• Adjuvant therapy. Specialists use post-operative radiotherapy or intensified chemotherapy for advanced stage III–IV cases.
• Multi-drug regimens. Standard protocols include combinations of vincristine, actinomycin-D, and doxorubicin to target cancer cells.

Bookimed Expert Insight: Turkish specialists emphasize integrated care by holding dual certifications in surgery and oncology. Dr. Ahmet Nadir Tosyali at Anadolu Medical Center is trained in both fields, which eliminates the need for external coordination between surgical and medical teams during complex tumor resections.

Patient Consensus: Parents noticed that chemotherapy often begins for several weeks before the surgery happens. Many mention that frequent blood draws are necessary throughout the process and suggest using ginger to help with nausea after treatments.

Turkish specialists manage Wilms tumor drug shortages by substituting unavailable medicines like actinomycin-D with carboplatin to maintain a 90% survival rate. Experts like Dr. Hilmi Apak and Dr. Ceyhun Bozkurt utilize international sourcing and compassionate use programs to provide unregistered life-saving treatments for children.

• Clinical substitution. Specialists use carboplatin to replace actinomycin-D without reducing the high patient survival rates.
• Compassionate use. Doctors provide free, unapproved treatments when standard options are unavailable or have failed.
• Administrative leadership. Prof. Dr. Yesim Yildirim uses healthcare management expertise to coordinate drug inventory effectively.
• Precise dosing. Care teams focus on waste reduction and prioritizing doses for children with urgent needs.

Bookimed Expert Insight: Turkish oncology leaders at centers like Anadolu combine academic research with administrative MBA training to navigate supply logistics. For instance, Dr. Hilmi Apak and Prof. Dr. Yesim Yildirim hold leadership roles that allow them to integrate international research with local inventory management. This dual focus helps them secure imported therapies from EU markets while maintaining research-backed alternative clinical protocols.

Patient Consensus: Patients are often relieved that their doctors have already planned alternative treatments during supply interruptions. They notice that the transition between different medicines happens smoothly without delaying the child's chemotherapy schedule.

In Turkey, specialists use the SIOP-based TPOG protocol, which prioritizes chemotherapy before surgery for children with Wilms tumor. This approach focuses on shrinking the tumor first to prevent rupture during its removal, leading to safer surgical results and better preservation of healthy kidney tissue.

• Initial treatment. Doctors typically start with four weeks of chemotherapy to reduce the tumor's size.
• Surgical timing. Surgeons like Dr. Ahmet Nadir Tosyali perform radical nephrectomies after the induction phase.
• Bilateral cases. For tumors in both kidneys, chemotherapy may continue for 120+ days before surgery.
• Adjuvant phase. Post-surgery chemotherapy is tailored based on the tumor's stage and specific cell histology.

Bookimed Expert Insight: Turkish oncology centers often use an integrated model where a single specialist holds dual qualifications in both pediatric surgery and oncology. Specialists like Dr. Ahmet Nadir Tosyali at Anadolu Medical Center provide this coordinated care, which simplifies the transition between the 4-week chemotherapy phase and the subsequent surgical intervention.

Patient Consensus: Parents often notice that the initial chemotherapy helps their children feel better before the major surgery. They frequently mention feeling reassured by specialists who explain how shrinking the tumor first makes the operation less complex.

Turkey provides multidisciplinary follow-up care through coordinated teams of pediatric oncologists, surgeons, and radiologists. Specialists like Dr. Hilmi Apak and Dr. Ahmet Nadir Tosyali manage long-term surveillance, focusing on kidney function, heart health, and early detection of recurrence using advanced imaging and blood analysis.

• Oncology leadership. Specialists like Dr. Hilmi Apak lead tailored surveillance schedules and chemotherapy monitoring.
• Surgical monitoring. Dr. Ahmet Nadir Tosyali tracks recovery and checks for potential abdominal complications.
• Academic expertise. Dr. Metin Demirkaya provides university-level care standards for complex pediatric cancer tracking.
• Specialized diagnostics. Follow-up includes quarterly ultrasounds, chest X-rays, and blood tests to ensure remission.

Bookimed Expert Insight: Patients benefit from dual-specialist expertise in Turkish centers. For example, some specialists are certified in both pediatric surgery and oncology. This combination allows one doctor to manage surgical recovery while simultaneously monitoring chemotherapy side effects. This reduces the need for separate appointments and improves care continuity.

Patient Consensus: Families value coordinated tumor boards that combine insights from oncologists and pediatric surgeons. Many recommend university hospitals where urolygists and cardiologists assist in monitoring kidney and heart health long-term.

医療はトルコ政府にとって重要な開発分野である。トルコ当局は、国民の健康管理は国家政策の絶対的な優先事項であるべきだと考えており、医療に年間約770億リラを支出している。

その結果、国内の28,000の医療機関が優れた医療を提供している。そのうち約50の施設は、世界中の医療サービスの質と安全性を向上させる国際機関であるJCI（国際医療機関評価機構）の認証を受けている。これらの施設は、認証取得数において最も高い水準を誇っている。比較すると、 イスラエルにはJCI認証を受けた医療機関が20施設あるのに対し、ドイツにはわずか10施設しかない。

トルコには、価格帯やサービスレベルが異なる様々なホテルがあります。トルコのホテルの水準は、チュニジア、モロッコ、エジプトのホテルと同等です。ほとんどの観光客は、食事付きの4つ星または5つ星ホテルを選びます。これらのホテルは、豊富な食事の選択肢、広々とした手入れの行き届いた敷地、子供から大人まで楽しめるエンターテイメントなど、快適な滞在に必要なすべてを提供しています。一部のホテルには、宿泊客が無料で利用できるウォーターパークがあります。予算重視の旅行者は、ハーフボードまたは食事なしの経済的な3つ星ホテルを予約することもできます。

トルコのリゾート地の最大の魅力は、長いビーチシーズンです。地中海沿岸では4月から11月まで、エーゲ海沿岸では5月から10月までがビーチシーズンとなります。泳ぐのに最も快適な時期は6月中旬から10月末までです。観光客が最も多く訪れるのは7月と8月で、この時期の気温は38℃、水温は27℃まで上昇します。

2020年現在、トルコ共和国は89カ国とビザ免除協定を結んでいます。一部の外国人は入国ビザが免除され、その他は電子ビザ（e-ビザ）が必要となり、さらにその他はトルコ在外公館でビザを申請する必要があります。

トルコで治療を受ける際にビザが必要な国と、国境を容易かつ簡単に越えられる国については、こちらをご覧ください。

トルコへの渡航ビザには、いくつかの書類が必要です。必要な書類は、出発予定日の90日前から提出できます。必要な書類は以下のとおりです。

• 身分証明書
• オンライン登録の確認とフォームへの記入
• 収入証明書および資金の確保状況（1人1日あたり50ドル）
• トルコ滞在保険証書（原本とコピー）
• 写真2枚（5×6インチ）
• ビザの取得
• 航空券とホテルの予約
• 治療の必要性に関する医師の結論。